'Click' D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity

被引:38
|
作者
Zhang, Jing [2 ]
Zhang, Hai [1 ]
Cai, Wenxian [1 ]
Yu, Leiping [1 ]
Zhen, Xuechu [1 ]
Zhang, Ao [2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Neuropharmacol Lab, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, SOMCL, Shanghai 201203, Peoples R China
基金
美国国家科学基金会;
关键词
Arylbenzazepine; Arylpiperazine; Click reaction; Dopamine receptor; Serotonin 5-HT1A receptor; PARKINSONS-DISEASE; SEROTONIN; LIGANDS; COMPLICATIONS; DOPAMINE-D-2; THERAPEUTICS; DERIVATIVES; THERAPY;
D O I
10.1016/j.bmc.2009.06.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D-1 receptor agonistic pharmacophore and a 5-HT1A receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D-1 receptor, but most compounds are potent at both D-2 and 5-HT1A receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K-i values of 144, 80, and 133 nM, for the D-1, D-2, and 5-HT1A receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D-2 receptor with K-i value of 19 nM. This compound also showed moderate affinity at the 5-HT1A (K-i, 105 nM), and D-1 (K-i, 551 nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D-1 and D-2 receptors, whereas full agonistic activity at the 5-HT1A receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D-2 antagonist and 5-HT1A agonist. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4873 / 4880
页数:8
相关论文
共 50 条
  • [31] Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists
    A. Tapia-Bustos
    R. Perez-Lobos
    V. Vío
    C. Lespay-Rebolledo
    E. Palacios
    A. Chiti-Morales
    D. Bustamante
    M. Herrera-Marschitz
    P. Morales
    Neurotoxicity Research, 2017, 31 : 109 - 121
  • [32] Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists
    Tapia-Bustos, A.
    Perez-Lobos, R.
    Vio, V.
    Lespay-Rebolledo, C.
    Palacios, E.
    Chiti-Morales, A.
    Bustamante, D.
    Herrera-Marschitz, M.
    Morales, P.
    NEUROTOXICITY RESEARCH, 2017, 31 (01) : 109 - 121
  • [33] Synergistic activation of the nitrergic system of the nucleus accumbens by dopamine D1 and D2 receptor agonists
    Saul'Skaya N.B.
    Terekhova E.A.
    Neuroscience and Behavioral Physiology, 2014, 44 (4) : 371 - 375
  • [34] Computational Pharmacophore Modelling of 5-HT2a and D2 Receptor Inhibitors of Schizophrenia
    Zainab, Rida
    Elahi, Sana
    Kaleem, Afshan
    Hoessli, Daniel C.
    Iqtedar, Mehwish
    Abdullah, Roheena
    Saleem, Faiza
    Khan, Shanza
    Ijaz, Anusha
    Naz, Shagufta
    Shakoori, Abdul R.
    PAKISTAN JOURNAL OF ZOOLOGY, 2018, 50 (06) : 2331 - 2342
  • [35] Evidence against dopamine D1/D2 receptor heteromers
    Frederick, A. L.
    Yano, H.
    Trifilieff, P.
    Vishwasrao, H. D.
    Biezonski, D.
    Meszaros, J.
    Urizar, E.
    Sibley, D. R.
    Kellendonk, C.
    Sonntag, K. C.
    Graham, D. L.
    Colbran, R. J.
    Stanwood, G. D.
    Javitch, J. A.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1373 - 1385
  • [36] Dopamine D1–D2 receptor heterodimers: A literature review
    Vekshina N.L.
    Anokhin P.K.
    Veretinskaya A.G.
    Shamakina I.Y.
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (2) : 111 - 119
  • [37] PET STUDIES ON D1 AND D2 RECEPTOR STATUS IN CHOREA
    TURJANSKI, N
    BURN, DJ
    LAMMERTSMA, AA
    DOLAN, R
    HARDING, AE
    QUINN, N
    KENNARD, C
    BROOKS, DJ
    NEUROLOGY, 1993, 43 (04) : A333 - A333
  • [38] DOPAMINE RECEPTOR SUBTYPES - BEYOND THE D1/D2 CLASSIFICATION
    ANDERSEN, PH
    GINGRICH, JA
    BATES, MD
    DEARRY, A
    FALARDEAU, P
    SENOGLES, SE
    CARON, MG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (06) : 231 - 236
  • [39] D1 AND D2 DOPAMINE RECEPTOR MECHANISMS IN DOPAMINERGIC BEHAVIORS
    KOLLER, WC
    HERBSTER, G
    CLINICAL NEUROPHARMACOLOGY, 1988, 11 (03) : 221 - 231
  • [40] Adolescent Maturation of D1 and D2 Dopamine Receptor Interactions
    Dwyer, Jennifer Buenzle
    Martinez, Lesly
    Ganddini, Gabriela
    Perez, Mayra
    Leslie, Frances M.
    FASEB JOURNAL, 2010, 24